YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2023Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial JAMA ONCOLOGY
2023Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 InsertionsNEW ENGLAND JOURNAL OF MEDICINE
2023Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy ACTA ONCOLOGICA
2023Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis JOURNAL OF THORACIC ONCOLOGY
2023How early can atherosclerosis be detected by coronary CT angiography? Insights from quantitative CT analysis of serial scans in the PARADIGM trial JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY
2023Management of HER2 alterations in non-small cell lung cancer - The past, present, and futureLUNG CANCER
2023Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON) LUNG CANCER
2023Reconstruction of Partially Broken Vascular Structures in X-Ray Images via Vesselness-Loss-Based Multi-Scale Generative Adversarial Networks IEEE ACCESS
2023Tarlatamab for Patients with Previously Treated Small-Cell Lung CancerNEW ENGLAND JOURNAL OF MEDICINE
2023High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma JHEP REPORTS
2023Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer NEW ENGLAND JOURNAL OF MEDICINE
2023INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) BMC CANCER
2023VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 studyANNALS OF ONCOLOGY
2023PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinomaNATURE CELL BIOLOGY
2023Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20) CANCER RESEARCH AND TREATMENT
2024Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH TrialJOURNAL OF CLINICAL ONCOLOGY
2023The Association Between On-treatment Ambulatory Central Blood Pressure and Left Ventricular Reverse Remodeling in Heart Failure With Reduced Ejection Fraction International Journal of Heart Failure
2023Margin-negative minimally invasive pancreatoduodenectomy following FOLFIRINOX neoadjuvant chemotherapy in invasive intraductal papillary mucinous neoplasm of pancreas: a case report Korean Journal of Clinical Oncology(대한임상종양학회지)
2024Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial NATURE COMMUNICATIONS
2023Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke NEUROLOGY
1 20 2122232425262728293031 691

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links